Defining immune-evasive mechanical signaling in head and neck cancer
- Institution
- BOSTON UNIVERSITY MEDICAL CAMPUS, MA
- Principal investigator
- Xaralabos Varelas
- Funding
- $676K
- Duration
- 2024–2029
Moonbase score
Still being scored
Abstract
Project Summary Head and neck cancer squamous cell carcinomas (HNSCC) are the seventh most common cancers globally and are associated with poor survival rates. Pharmacological treatments for HNSCC remain largely ineffective and improving therapies requires the identification of novel factors that modulate not just the tumor but also the surrounding permissive oral microenvironment. Aging is a variable tightly associated with HNSCC development and is linked to tissue alterations and defective immune responses. However, while older chronological age is associated with tumor development and elderly HNSCC patients exhibit worse five-year survival, very little is known about the molecular mechanisms by which aging contributes to the etiology of HNSCC. The goal of this proposal is to define signals associated with HNSCC progression in aged tissues with the hope to uncover targetable mechanisms that may offer new therapeutic avenues. To test the influence of age on HNSCC, we optimized syngeneic orthotopic tongue xenograft models of HNSCC and have observed more rapid tumor growth in old animals, with tumors exhibiting an age-associated, immune evasive and transcriptionally-distinct tumor cell states. We have found that these age-associated alterations correlate with increased extracellular matrix levels that we hypothesize the mechanical properties of old tissues direct distinct mechanosensitive signals. Our observations suggest that the mechanical-effector YAP, a transcriptional regulator mediating Hippo pathway signaling that has pro-tumorigenic functions in HNSCC, is linked to age-associated tumorigenesis. We propose to examine the relationship between aging, extracellular matrix dynamics, YAP activity and YAP-directed functions, including immune evasion. We further plan to compare matrix dynamics and tissue elasticity across mice of different chronological age and test how increasing collagen levels or reducing collagen crosslinking affects tumorigenic behavior. We will further test the consequences of inhibiting YAP activity in age-associated tumors, profiling accompanying transcriptional and cellular changes. Finally, we will test how reintroducing an absent chemokine program regulated by YAP that is repressed in the old tongue microenvironment impacts tumor growth and tumor lymphocyte infiltration. Data collected from our study will provide a comprehensive assessment of age-associated mechanical signals and offer new insight into mechanisms that may direct the heterogenous lymphocytic functions observed in HNSCC.
Research team
- Maria A. KukuruzinskaPI
- Stefano MontiPI
- Xaralabos VarelasPI
LOADING MOONBASE SCORE
Questions for BOSTON UNIVERSITY MEDICAL CAMPUS
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Boston University Medical Campus54
Defining the β-catenin/CBP-catenin/CBP axis in head and neck cancer
Maria A. Kukuruzinska · $554K · 2020–2026
- NIH · Boston University Medical Campus66
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study
Rhoda Au · $569K · 2021–2027
- NIH · Boston University Medical Campus65
Blood Biomarker Development and Validation in Chronic Traumatic Encephalopathy and Alzheimer's Disease and Alzheimer's Disease Related Dementias
Michael Alosco · $972K · 2023–2028